Go Pro

SeaStar Medical (ICU) Competitors

SeaStar Medical logo
$3.03 -0.10 (-3.19%)
Closing price 09/11/2026 03:59 PM Eastern
Extended Trading
$3.04 +0.01 (+0.20%)
As of 09/11/2026 07:53 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

ICU vs. SRTS, MDAI, POCI, BDMD, and PAVM

Should you buy SeaStar Medical stock or one of its competitors? SeaStar Medical's main competitors and comparable companies include Sensus Healthcare (SRTS), Spectral AI (MDAI), Precision Optics (POCI), Baird Medical Investment (BDMD), and PAVmed (PAVM). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does SeaStar Medical compare to Sensus Healthcare?

SeaStar Medical (NASDAQ:ICU) and Sensus Healthcare (NASDAQ:SRTS) are both small-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, analyst recommendations, valuation, institutional ownership, media sentiment, dividends, earnings and risk.

In the previous week, Sensus Healthcare had 1 more articles in the media than SeaStar Medical. MarketBeat recorded 3 mentions for Sensus Healthcare and 2 mentions for SeaStar Medical. SeaStar Medical's average media sentiment score of 0.93 beat Sensus Healthcare's score of 0.88 indicating that SeaStar Medical is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
SeaStar Medical
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Sensus Healthcare
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

SeaStar Medical currently has a consensus price target of $8.00, indicating a potential upside of 164.03%. Sensus Healthcare has a consensus price target of $5.83, indicating a potential upside of 85.19%. Given SeaStar Medical's higher possible upside, equities analysts clearly believe SeaStar Medical is more favorable than Sensus Healthcare.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
SeaStar Medical
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
Sensus Healthcare
1 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.50

Sensus Healthcare has higher revenue and earnings than SeaStar Medical. Sensus Healthcare is trading at a lower price-to-earnings ratio than SeaStar Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SeaStar Medical$1.23M10.86-$12.15M-$3.91N/A
Sensus Healthcare$27.48M1.89-$7.72M-$0.94N/A

SeaStar Medical has a beta of -1.05, meaning that its share price is 205% less volatile than the broader market. Comparatively, Sensus Healthcare has a beta of 1.13, meaning that its share price is 13% more volatile than the broader market.

1.7% of SeaStar Medical shares are held by institutional investors. Comparatively, 25.3% of Sensus Healthcare shares are held by institutional investors. 0.7% of SeaStar Medical shares are held by insiders. Comparatively, 10.2% of Sensus Healthcare shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Sensus Healthcare has a net margin of -88.45% compared to SeaStar Medical's net margin of -795.51%. Sensus Healthcare's return on equity of -21.57% beat SeaStar Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
SeaStar Medical-795.51% -162.75% -109.89%
Sensus Healthcare -88.45%-21.57%-19.20%

Summary

Sensus Healthcare beats SeaStar Medical on 12 of the 16 factors compared between the two stocks.

How does SeaStar Medical compare to Spectral AI?

Spectral AI (NASDAQ:MDAI) and SeaStar Medical (NASDAQ:ICU) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, dividends, media sentiment, profitability, earnings and risk.

Spectral AI has a net margin of -69.27% compared to SeaStar Medical's net margin of -795.51%. Spectral AI's return on equity of 0.00% beat SeaStar Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Spectral AI-69.27% N/A -78.56%
SeaStar Medical -795.51%-162.75%-109.89%

67.1% of Spectral AI shares are held by institutional investors. Comparatively, 1.7% of SeaStar Medical shares are held by institutional investors. 13.7% of Spectral AI shares are held by company insiders. Comparatively, 0.7% of SeaStar Medical shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Spectral AI has a beta of 1.18, indicating that its share price is 18% more volatile than the broader market. Comparatively, SeaStar Medical has a beta of -1.05, indicating that its share price is 205% less volatile than the broader market.

Spectral AI has higher revenue and earnings than SeaStar Medical. Spectral AI is trading at a lower price-to-earnings ratio than SeaStar Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Spectral AI$19.65M2.62-$7.57M-$0.35N/A
SeaStar Medical$1.23M10.86-$12.15M-$3.91N/A

Spectral AI presently has a consensus price target of $4.00, indicating a potential upside of 150.00%. SeaStar Medical has a consensus price target of $8.00, indicating a potential upside of 164.03%. Given SeaStar Medical's higher probable upside, analysts clearly believe SeaStar Medical is more favorable than Spectral AI.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Spectral AI
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
2.67
SeaStar Medical
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

In the previous week, Spectral AI had 1 more articles in the media than SeaStar Medical. MarketBeat recorded 3 mentions for Spectral AI and 2 mentions for SeaStar Medical. SeaStar Medical's average media sentiment score of 0.93 beat Spectral AI's score of 0.82 indicating that SeaStar Medical is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Spectral AI
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
SeaStar Medical
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Spectral AI beats SeaStar Medical on 12 of the 16 factors compared between the two stocks.

How does SeaStar Medical compare to Precision Optics?

Precision Optics (NASDAQ:POCI) and SeaStar Medical (NASDAQ:ICU) are both small-cap healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, valuation, analyst recommendations, dividends, media sentiment, institutional ownership, risk and earnings.

13.7% of Precision Optics shares are held by institutional investors. Comparatively, 1.7% of SeaStar Medical shares are held by institutional investors. 14.4% of Precision Optics shares are held by company insiders. Comparatively, 0.7% of SeaStar Medical shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

In the previous week, Precision Optics had 2 more articles in the media than SeaStar Medical. MarketBeat recorded 4 mentions for Precision Optics and 2 mentions for SeaStar Medical. SeaStar Medical's average media sentiment score of 0.93 beat Precision Optics' score of 0.72 indicating that SeaStar Medical is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Precision Optics
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
SeaStar Medical
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Precision Optics has a net margin of -17.03% compared to SeaStar Medical's net margin of -795.51%. Precision Optics' return on equity of -37.47% beat SeaStar Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Precision Optics-17.03% -37.47% -19.96%
SeaStar Medical -795.51%-162.75%-109.89%

Precision Optics has higher revenue and earnings than SeaStar Medical. Precision Optics is trading at a lower price-to-earnings ratio than SeaStar Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Precision Optics$19.09M2.50-$5.78M-$0.63N/A
SeaStar Medical$1.23M10.86-$12.15M-$3.91N/A

Precision Optics has a beta of 0.32, indicating that its stock price is 68% less volatile than the broader market. Comparatively, SeaStar Medical has a beta of -1.05, indicating that its stock price is 205% less volatile than the broader market.

SeaStar Medical has a consensus price target of $8.00, suggesting a potential upside of 164.03%. Given SeaStar Medical's stronger consensus rating and higher probable upside, analysts clearly believe SeaStar Medical is more favorable than Precision Optics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Precision Optics
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
SeaStar Medical
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

Summary

Precision Optics beats SeaStar Medical on 10 of the 16 factors compared between the two stocks.

How does SeaStar Medical compare to Baird Medical Investment?

SeaStar Medical (NASDAQ:ICU) and Baird Medical Investment (NASDAQ:BDMD) are both small-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, institutional ownership, earnings, dividends, profitability, risk, valuation and analyst recommendations.

Baird Medical Investment has higher revenue and earnings than SeaStar Medical.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SeaStar Medical$1.23M10.86-$12.15M-$3.91N/A
Baird Medical Investment$22.54M2.06N/AN/AN/A

Baird Medical Investment has a net margin of 0.00% compared to SeaStar Medical's net margin of -795.51%. Baird Medical Investment's return on equity of 0.00% beat SeaStar Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
SeaStar Medical-795.51% -162.75% -109.89%
Baird Medical Investment N/A N/A N/A

SeaStar Medical presently has a consensus target price of $8.00, indicating a potential upside of 164.03%. Given SeaStar Medical's stronger consensus rating and higher probable upside, equities analysts clearly believe SeaStar Medical is more favorable than Baird Medical Investment.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
SeaStar Medical
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
Baird Medical Investment
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

SeaStar Medical has a beta of -1.05, meaning that its stock price is 205% less volatile than the broader market. Comparatively, Baird Medical Investment has a beta of -1.15, meaning that its stock price is 215% less volatile than the broader market.

1.7% of SeaStar Medical shares are owned by institutional investors. Comparatively, 19.8% of Baird Medical Investment shares are owned by institutional investors. 0.7% of SeaStar Medical shares are owned by company insiders. Comparatively, 78.9% of Baird Medical Investment shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

In the previous week, Baird Medical Investment had 1 more articles in the media than SeaStar Medical. MarketBeat recorded 3 mentions for Baird Medical Investment and 2 mentions for SeaStar Medical. Baird Medical Investment's average media sentiment score of 0.94 beat SeaStar Medical's score of 0.93 indicating that Baird Medical Investment is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
SeaStar Medical
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Baird Medical Investment
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Baird Medical Investment beats SeaStar Medical on 8 of the 13 factors compared between the two stocks.

How does SeaStar Medical compare to PAVmed?

SeaStar Medical (NASDAQ:ICU) and PAVmed (NASDAQ:PAVM) are both small-cap healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their media sentiment, institutional ownership, analyst recommendations, dividends, profitability, valuation, risk and earnings.

SeaStar Medical currently has a consensus price target of $8.00, indicating a potential upside of 164.03%. PAVmed has a consensus price target of $56.00, indicating a potential upside of 1,239.71%. Given PAVmed's higher possible upside, analysts plainly believe PAVmed is more favorable than SeaStar Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
SeaStar Medical
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
PAVmed
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

In the previous week, PAVmed had 1 more articles in the media than SeaStar Medical. MarketBeat recorded 3 mentions for PAVmed and 2 mentions for SeaStar Medical. PAVmed's average media sentiment score of 1.31 beat SeaStar Medical's score of 0.93 indicating that PAVmed is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
SeaStar Medical
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
PAVmed
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

PAVmed has lower revenue, but higher earnings than SeaStar Medical. SeaStar Medical is trading at a lower price-to-earnings ratio than PAVmed, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SeaStar Medical$1.23M10.86-$12.15M-$3.91N/A
PAVmed$70K477.71$400K-$16.05N/A

SeaStar Medical has a beta of -1.05, suggesting that its share price is 205% less volatile than the broader market. Comparatively, PAVmed has a beta of 0.53, suggesting that its share price is 47% less volatile than the broader market.

SeaStar Medical has a net margin of -795.51% compared to PAVmed's net margin of -10,794.64%. PAVmed's return on equity of -126.43% beat SeaStar Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
SeaStar Medical-795.51% -162.75% -109.89%
PAVmed -10,794.64%-126.43%-25.49%

1.7% of SeaStar Medical shares are held by institutional investors. Comparatively, 19.9% of PAVmed shares are held by institutional investors. 0.7% of SeaStar Medical shares are held by insiders. Comparatively, 13.4% of PAVmed shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Summary

PAVmed beats SeaStar Medical on 11 of the 14 factors compared between the two stocks.

Get SeaStar Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for ICU and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ICU and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ICU vs. The Competition

MetricSeaStar MedicalHealthcare Equipment & Supplies IndustryHealthcare SectorNASDAQ Exchange
Market Cap$13.35M$5.48B$7.16B$12.85B
Dividend YieldN/A1.80%2.57%11.17%
P/E Ratio-0.7725.09274.9425.36
Price / Sales10.8671.54686.57116.78
Price / CashN/A32.5776.6551.52
Price / Book1.105.9710.336.20
Net Income-$12.15M$150.75M$3.50B$358.50M
7 Day Performance1.68%-2.83%-3.32%-2.35%
1 Month Performance-4.42%-3.73%-0.53%-3.23%
1 Year Performance-65.18%9.38%23.51%8.79%

SeaStar Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ICU
SeaStar Medical
3.3111 of 5 stars
$3.03
-3.2%
$8.00
+164.0%
-65.2%$13.35M$1.23MN/A2
SRTS
Sensus Healthcare
3.4551 of 5 stars
$3.16
-0.9%
$5.83
+84.6%
-0.9%$52.51M$27.48MN/A40
MDAI
Spectral AI
1.9661 of 5 stars
$1.61
+2.5%
$4.00
+148.4%
-17.5%$50.53M$19.65MN/A83
POCI
Precision Optics
0.8197 of 5 stars
$4.39
+0.9%
N/A-1.1%$47.61M$19.09MN/A80
BDMD
Baird Medical Investment
1.3038 of 5 stars
$1.10
+0.9%
N/A-55.1%$46.01M$22.54MN/AN/A

Related Companies and Tools


This page (NASDAQ:ICU) was last updated on 9/13/2026 by MarketBeat.com Staff.
From Our Partners